Health Industry News
Seqirus to release additional 700,000 adult flu vaccine doses to help boost “community immunity” against preventable infection
Seqirus announced the manufacture of another 500,000 doses of their adult influenza vaccine, Afluria Quad (inactivated quadrivalent influenza vaccine, split virion) today to help meet increasing consumer demand. Having fulfilled the government’s request to re-enter production, Seqirus is now ahead of the National Immunisation Program (NIP) schedule, with its first vaccine set for release this…
Read MoreMundipharma pioneering prostate cancer research in Australia
A Medical Oncologist from Chris O’Brien Lifehouse, Sydney has recently clinched a $60,000 2018 Mundipharma ANZUP Uro-Oncology Clinical Research Fellowship to support her research into prostate cancer. Dr Kate Mahon is the fifth recipient of the annual Clinical Research Fellowship awarded in partnership with the Australian and New Zealand Urogenital and Prostate Cancer Trials Group…
Read MoreChildhood depression and obesity link
The most recent childhood obesity data is cause for concern, with almost 28 per cent of Australian children recorded as either overweight or obese in 2014-15. A recent meta-analysis of more than 51,000 study participants has revealed a positive link between childhood and adolescent obesity and depression. Australian kids who are overweight and obese are…
Read MoreAnnual Biotechnology Industry Survey reveals strongest recorded business sentiment across sector since 2011
Almost four-in-five (77 per cent) AusBiotech Industry Survey respondents described the past 12 months as ‘excellent’ or ‘good’ – a five per cent increase on the previous year, and the strongest result recorded since the survey’s inception in 2011. Furthermore, almost 90 per cent of respondents said they expect their business to grow in 2018,…
Read MoreProcedure guidance for medicines funded through Life Saving Drugs Program now available
VIVA! Communications congratulates the Department of Health for its publication of the long-awaited ‘Procedure guidance for medicines funded through the Government’s Life Savings Drugs Program (LSDP) – Version 1.0’. The procedural reform guidance outlines the consideration process for new life saving drugs, and medication reviews, among various other items. VIVA! Communications has a longstanding history…
Read More